Subcutaneous Actemra tocilizumab regulatory update

Chugai said in its 1Q12 earnings presentation that in March it submitted a regulatory application to Japan's Ministry of Health, Labor and Welfare (MHLW) for a subcutaneous formulation of Actemra toci...